Correlation Between Premier Biomedical and Verisante Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Premier Biomedical and Verisante Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Premier Biomedical and Verisante Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Premier Biomedical and Verisante Technology, you can compare the effects of market volatilities on Premier Biomedical and Verisante Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Premier Biomedical with a short position of Verisante Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Premier Biomedical and Verisante Technology.

Diversification Opportunities for Premier Biomedical and Verisante Technology

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Premier and Verisante is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Premier Biomedical and Verisante Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verisante Technology and Premier Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Premier Biomedical are associated (or correlated) with Verisante Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verisante Technology has no effect on the direction of Premier Biomedical i.e., Premier Biomedical and Verisante Technology go up and down completely randomly.

Pair Corralation between Premier Biomedical and Verisante Technology

Given the investment horizon of 90 days Premier Biomedical is expected to under-perform the Verisante Technology. But the pink sheet apears to be less risky and, when comparing its historical volatility, Premier Biomedical is 3.88 times less risky than Verisante Technology. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Verisante Technology is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  0.22  in Verisante Technology on September 13, 2025 and sell it today you would lose (0.01) from holding Verisante Technology or give up 4.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.44%
ValuesDaily Returns

Premier Biomedical  vs.  Verisante Technology

 Performance 
       Timeline  
Premier Biomedical 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Premier Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in January 2026. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Verisante Technology 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Verisante Technology are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating technical and fundamental indicators, Verisante Technology reported solid returns over the last few months and may actually be approaching a breakup point.

Premier Biomedical and Verisante Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Premier Biomedical and Verisante Technology

The main advantage of trading using opposite Premier Biomedical and Verisante Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Premier Biomedical position performs unexpectedly, Verisante Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verisante Technology will offset losses from the drop in Verisante Technology's long position.
The idea behind Premier Biomedical and Verisante Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA